Companies

Lyell Immunopharma, Inc. (LYEL) SEC filings

CIK 0001806952 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)3600084.7 M
Net income (USD)-183.1 M-250.2 M-204.5 M
Diluted EPS (USD/shares)-16.06-0.74

Latest filings

FiledFormDescriptionPeriod
2026-10-13442026-10-12
2026-09-10442026-09-10
2026-09-10442026-09-10
2026-09-10332026-08-31
2026-09-108-K8-K items 8.01,9.012026-09-10
2026-08-25442026-08-21
2026-08-25442026-08-21
2026-08-25442026-08-21
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-11442026-08-10
2026-08-11442026-08-10
2026-08-11442026-08-10
2026-08-11442026-08-10
2026-08-0610-Q10-Q2026-06-30
2026-08-068-K8-K items 2.02,9.012026-08-06
2026-07-274FORM 42026-07-27
2026-07-274FORM 42026-07-27
2026-07-21EFFECTEFFECT items ,,
2026-07-204FORM 42026-07-17
2026-07-174FORM 42026-07-16
2026-07-17CORRESPCORRESP
2026-07-16UPLOADUPLOAD
2026-07-13S-3S-3
2026-07-014FORM 42026-06-29
2026-06-18442026-06-15

Forms on file (last 1,000): 4 140, 8-K 56, 3 27, 10-Q 16, SCHEDULE 13G/A 12, CORRESP 12, UPLOAD 9, 144 8. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=LYEL (0.002 USD), /gw/filings/filings?ticker=LYEL&form=8-K, /gw/filings/facts?ticker=LYEL&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange